These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 25785115)

  • 21. Clinical, haemodynamic, anthropometric, metabolic and insulin profile of men with high-stage and high-grade clinical prostate cancer.
    Hammarsten J; Högstedt B
    Blood Press; 2004; 13(1):47-55. PubMed ID: 15083641
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High red blood cell distribution width is associated with the metabolic syndrome.
    Laufer Perl M; Havakuk O; Finkelstein A; Halkin A; Revivo M; Elbaz M; Herz I; Keren G; Banai S; Arbel Y
    Clin Hemorheol Microcirc; 2015 Sep; 63(1):35-43. PubMed ID: 26444609
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association between Benign Prostatic Hyperplasia and Neutrophil-Lymphocyte Ratio, an Indicator of Inflammation and Metabolic Syndrome.
    Ozer K; Horsanali MO; Gorgel SN; Horsanali BO; Ozbek E
    Urol Int; 2017; 98(4):466-471. PubMed ID: 27464069
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular Analysis of the SRD5A1 and SRD5A2 Genes in Patients with Benign Prostatic Hyperplasia with Regard to Metabolic Parameters and Selected Hormone Levels.
    Rył A; Rotter I; Grzywacz A; Małecka I; Skonieczna-Żydecka K; Grzesiak K; Słojewski M; Szylińska A; Sipak-Szmigiel O; Piasecka M; Walczakiewicz K; Laszczyńska M
    Int J Environ Res Public Health; 2017 Oct; 14(11):. PubMed ID: 29084161
    [No Abstract]   [Full Text] [Related]  

  • 25. Red blood cell distribution width and carotid intima-media thickness in patients with metabolic syndrome.
    Ren D; Wang J; Li H; Li Y; Li Z
    BMC Cardiovasc Disord; 2017 Jan; 17(1):44. PubMed ID: 28129745
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of metabolic syndrome on response to medical treatment of benign prostatic hyperplasia.
    Cyrus A; Kabir A; Goodarzi D; Talaei A; Moradi A; Rafiee M; Moghimi M; Shahbazi E; Farmani E
    Korean J Urol; 2014 Dec; 55(12):814-20. PubMed ID: 25512816
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Calculated fast-growing benign prostatic hyperplasia--a risk factor for developing clinical prostate cancer.
    Hammarsten J; Högstedt B
    Scand J Urol Nephrol; 2002; 36(5):330-8. PubMed ID: 12487736
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The correlation between metabolic syndrome and prostatic growth in patients with benign prostatic hyperplasia.
    Ozden C; Ozdal OL; Urgancioglu G; Koyuncu H; Gokkaya S; Memis A
    Eur Urol; 2007 Jan; 51(1):199-203; discussion 204-6. PubMed ID: 16806666
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Urinary prostate-specific antigen: predictor of benign prostatic hyperplasia progression?
    Pejcic TP; Tulic CDz; Lalic NV; Glisic BD; Ignjatovic SD; Markovic BB; Hadzi-Djokic JB
    Can J Urol; 2013 Apr; 20(2):6707-13. PubMed ID: 23587511
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Benign Prostatic Hyperplasia, Metabolic Syndrome and Non-Alcoholic Fatty Liver Disease: Is Metaflammation the Link?
    Russo GI; Cimino S; Castelli T; Favilla V; Gacci M; Carini M; Condorelli RA; La Vignera S; Calogero AE; Motta F; Puzzo L; Caltabiano R; Morgia G
    Prostate; 2016 Dec; 76(16):1528-1535. PubMed ID: 27458062
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Meta-analysis of metabolic syndrome and benign prostatic hyperplasia in Chinese patients.
    Zou C; Gong D; Fang N; Fan Y
    World J Urol; 2016 Feb; 34(2):281-9. PubMed ID: 26119349
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tissue immunoexpression of IL-6 and IL-18 in aging men with BPH and MetS and their relationship with lipid parameters and gut microbiota-derived short chain fatty acids.
    Ratajczak W; Laszczyńska M; Rył A; Dołęgowska B; Sipak O; Stachowska E; Słojewski M; Lubkowska A
    Aging (Albany NY); 2023 Oct; 15(20):10875-10896. PubMed ID: 37847180
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Correlates of zinc finger BED domain-containing protein 3 and ghrelin in metabolic syndrome patients with and without prediabetes.
    AbuZayed R; Bulatova N; Kasabri V; Suyagh M; Halaseh L; AlAlawi S
    Horm Mol Biol Clin Investig; 2019 Jan; 37(3):. PubMed ID: 30667367
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Components of the metabolic syndrome-risk factors for the development of benign prostatic hyperplasia.
    Hammarsten J; Högstedt B; Holthuis N; Mellström D
    Prostate Cancer Prostatic Dis; 1998 Mar; 1(3):157-162. PubMed ID: 12496910
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Associations between metabolic syndrome and clinical benign prostatic hyperplasia in a northern urban Han Chinese population: A prospective cohort study.
    Zhao SC; Xia M; Tang JC; Yan Y
    Sci Rep; 2016 Sep; 6():33933. PubMed ID: 27653367
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The relationship between red blood cell distribution width and metabolic syndrome in elderly Chinese: a cross-sectional study.
    Yan Z; Fan Y; Meng Z; Huang C; Liu M; Zhang Q; Song K; Jia Q
    Lipids Health Dis; 2019 Jan; 18(1):34. PubMed ID: 30704536
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Heme oxygenase levels and metaflammation in benign prostatic hyperplasia patients.
    Russo GI; Vanella L; Castelli T; Cimino S; Reale G; Urzì D; Li Volti G; Gacci M; Carini M; Motta F; Caltabiano R; Puzzo L; Sorrenti V; Morgia G
    World J Urol; 2016 Aug; 34(8):1183-92. PubMed ID: 26621207
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association of metabolic syndrome and benign prostatic hyperplasia in Chinese patients of different age decades.
    Pan JG; Jiang C; Luo R; Zhou X
    Urol Int; 2014; 93(1):10-6. PubMed ID: 24246728
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Red Blood Cell Distribution Width is a Reliable Marker of Inflammation in Plaque Psoriasis.
    Doğan S; Atakan N
    Acta Dermatovenerol Croat; 2017 Apr; 25(1):26-31. PubMed ID: 28511747
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Benign prostatic enlargement can be influenced by metabolic profile: results of a multicenter prospective study.
    Gacci M; Sebastianelli A; Salvi M; De Nunzio C; Vignozzi L; Corona G; Jaeger T; Chini T; Russo GI; Maggi M; Morgia G; Tubaro A; Carini M; Serni S
    BMC Urol; 2017 Apr; 17(1):22. PubMed ID: 28376747
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.